Core Scientificās Biggest Shareholder Rejects CoreWeave Deal, Cites Undervaluation
TL;DR Two Seas Capital, the largest active shareholder in Core Scientific, opposes the proposed $9 billion all-stock acquisition by CoreWeave, calling the valuation inadequate. They warn